Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. (CTXR) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)

SC 13G/ACTXRFiled Aug 14, 2026, 10:42 AM ET

About this filing

Citius Pharmaceuticals, Inc. (CTXR) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Aug 14, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

View original filing on SEC.gov

Key facts

Document: —

More CTXR filings

8-K
Current report
Filed Oct 26, 2026
8-K
Current report
Filed Aug 21, 2026
10-Q
Quarterly report
Filed Aug 14, 2026
8-K
Current report
Filed Aug 14, 2026
UPLOAD
SEC filing
Filed Aug 10, 2026
8-K
Current report
Filed Aug 5, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.